AMY1A | Amylase, alpha 1A (salivary) | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/4310/ihc_cell_selected_60x60.jpg) | ![](/images/4310/96774_B_1_7_rna_selected_60x60.jpg) | Group enriched |
SLC5A5 | Solute carrier family 5 (sodium/iodide cotransporter), member 5 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/22364/ihc_cell_selected_60x60.jpg) | ![](/images/22364/49656_A_3_5_rna_selected_60x60.jpg) | Group enriched |
AMY1C | Amylase, alpha 1C (salivary) | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45394/119576_B_4_1_rna_selected_60x60.jpg) | Group enriched |
AMY1B | Amylase, alpha 1B (salivary) | Enzymes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45399/119584_B_4_1_rna_selected_60x60.jpg) | Group enriched |
FXYD2 | FXYD domain containing ion transport regulator 2 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| ![](/images/4649/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/4649/11878_B_9_3_rna_selected_60x60.jpg) | Group enriched |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | ![](/images/49491/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/60121/145140_B_8_3_rna_selected_60x60.jpg) | Group enriched |
BSND | Bartter syndrome, infantile, with sensorineural deafness (Barttin) | Disease related genes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/53836/ihc_cell_selected_60x60.jpg) | ![](/images/53836/123883_B_9_7_rna_selected_60x60.jpg) | Group enriched |
KLK1 | Kallikrein 1 | Enzymes Predicted secreted proteins
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
TMEM213 | Transmembrane protein 213 | Predicted membrane proteins Predicted secreted proteins
| ![](/images/54059/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/54059/124880_B_9_1_rna_selected_60x60.jpg) | Group enriched |
CALML5 | Calmodulin-like 5 | Plasma proteins RAS pathway related proteins
| | ![](/images/40725/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/40725/88884_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC13A5 | Solute carrier family 13 (sodium-dependent citrate transporter), member 5 | Predicted membrane proteins Transporters
| ![](/images/44343/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44343/97195_B_9_2_rna_selected_60x60.jpg) | Group enriched |
C6orf58 | Chromosome 6 open reading frame 58 | Predicted secreted proteins
| ![](/images/36263/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/36263/72375_A_3_8_rna_selected_60x60.jpg) | Group enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34083/74043_B_6_7_rna_selected_60x60.jpg) | Group enriched |
LRRC26 | Leucine rich repeat containing 26 | Cytoskeleton related proteins Predicted membrane proteins
| ![](/images/56312/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/56312/129077_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TLX1 | T-cell leukemia homeobox 1 | Cancer-related genes Disease related genes Transcription factors
| ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
LMAN1L | Lectin, mannose-binding, 1 like | Predicted membrane proteins
| ![](/images/51206/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51206/119714_B_8_2_rna_selected_60x60.jpg) | Group enriched |
TFAP2B | Transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| ![](/images/34683/ihc_selected_60x60.jpg) | ![](/images/34683/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/34683/82207_B_7_2_rna_selected_60x60.jpg) | Group enriched |
ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images/18029/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18029/40901_B_8_2_rna_selected_60x60.jpg) | Group enriched |
MUC19 | Mucin 19, oligomeric | Predicted secreted proteins
| ![](/images/63994/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/63994/141880_B_7_6_rna_selected_60x60.jpg) | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted membrane proteins
| ![](/images/10510/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10510/62797_B_8_2_rna_selected_60x60.jpg) | Group enriched |
NXPE4 | Neurexophilin and PC-esterase domain family, member 4 | Predicted secreted proteins
| ![](/images/42801/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42801/95106_B_8_1_rna_selected_60x60.jpg) | Group enriched |
C5orf46 | Chromosome 5 open reading frame 46 | Predicted secreted proteins
| ![](/images/58999/ihc_selected_60x60.jpg) | ![](/images/58999/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/58999/131550_B_2_3_rna_selected_60x60.jpg) | Group enriched |
DMBT1 | Deleted in malignant brain tumors 1 | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/40778/142067_B_9_7_rna_selected_60x60.jpg) | Group enriched |
TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 | Predicted membrane proteins Transporters Voltage-gated ion channels
| ![](/images/62864/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62864/140541_B_8_2_rna_selected_60x60.jpg) | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | ![](/images/57599/ihc_selected_60x60.jpg) | ![](/images/38648/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/57599/143133_A_1_8_rna_selected_60x60.jpg) | Group enriched |
CHRM1 | Cholinergic receptor, muscarinic 1 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| ![](/images/14101/ihc_selected_60x60.jpg) | ![](/images/22366/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14101/151887_B_8_1_rna_selected_60x60.jpg) | Group enriched |
DHRS2 | Dehydrogenase/reductase (SDR family) member 2 | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | ![](/images/1893/5702_A_1_5_rna_selected_60x60.jpg) | Group enriched |
AC005488.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
AC006014.1 | Uncharacterized protein | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Group enriched |
CLCNKB | Chloride channel, voltage-sensitive Kb | Disease related genes Predicted membrane proteins
| ![](/images/57717/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/57717/149085_A_1_6_rna_selected_60x60.jpg) | Group enriched |
ETNPPL | Ethanolamine-phosphate phospho-lyase | Enzymes Mitochondrial proteins
| ![](/images/44546/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/44546/103901_A_4_3_rna_selected_60x60.jpg) | Group enriched |
KIAA1024 | KIAA1024 | Predicted membrane proteins
| ![](/images/11545/ihc_selected_60x60.jpg) | ![](/images/11545/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/11545/28608_B_8_2_rna_selected_60x60.jpg) | Group enriched |
SLC13A2 | Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14963/141351_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ZNF750 | Zinc finger protein 750 | Cancer-related genes Disease related genes
| | ![](/images/21573/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21573/50402_B_8_6_rna_selected_60x60.jpg) | Group enriched |
ADARB2 | Adenosine deaminase, RNA-specific, B2 (non-functional) | | ![](/images/31333/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/31333/66686_B_8_5_rna_selected_60x60.jpg) | Group enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25669/59312_B_2_4_rna_selected_60x60.jpg) | Group enriched |
CFTR | Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21939/147487_B_6_5_rna_selected_60x60.jpg) | Group enriched |
DNER | Delta/notch-like EGF repeat containing | Cancer-related genes Predicted membrane proteins
| ![](/images/17320/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17320/40661_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ERBB4 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 4 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| ![](/images/276/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/12016/35975_B_7_6_rna_selected_60x60.jpg) | Group enriched |
KRT23 | Keratin 23 (histone deacetylase inducible) | | ![](/images/12050/ihc_selected_60x60.jpg) | ![](/images/17091/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16959/39456_B_5_3_rna_selected_60x60.jpg) | Group enriched |
MIA | Melanoma inhibitory activity | Cancer-related genes Predicted secreted proteins
| ![](/images/42369/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42369/94157_B_5_1_rna_selected_60x60.jpg) | Group enriched |
NKAIN3 | Na+/K+ transporting ATPase interacting 3 | Predicted membrane proteins
| ![](/images/18833/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18833/42487_A_5_6_rna_selected_60x60.jpg) | Group enriched |
PAX9 | Paired box 9 | Disease related genes Transcription factors
| ![](/images/38462/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/38462/79558_B_9_1_rna_selected_60x60.jpg) | Group enriched |
PITX1 | Paired-like homeodomain 1 | Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/8743/23430_B_7_4_rna_selected_60x60.jpg) | Group enriched |
PTCH2 | Patched 2 | Cancer-related genes Disease related genes Predicted membrane proteins
| ![](/images/46839/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46839/109074_A_3_7_rna_selected_60x60.jpg) | Group enriched |
S100A1 | S100 calcium binding protein A1 | Cancer-related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/2599/6674_B_4_1_rna_selected_60x60.jpg) | Group enriched |
VSIG10L | V-set and immunoglobulin domain containing 10 like | Predicted membrane proteins
| ![](/images/60453/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images/60453/ihc_cell_selected_60x60.jpg) | ![](/images/60453/136022_B_8_3_rna_selected_60x60.jpg) | Group enriched |
ATP6V1C2 | ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2 | Transporters
| ![](/images/34734/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/34734/75429_A_3_1_rna_selected_60x60.jpg) | Group enriched |
GLYATL2 | Glycine-N-acyltransferase-like 2 | Enzymes Mitochondrial proteins
| ![](/images/60292/ihc_selected_60x60.jpg) | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/60292/133888_A_4_5_rna_selected_60x60.jpg) | Group enriched |